title: Optimal revascularization strategy for diabetic patients with multivessel coronary artery disease: the duel between old hero and young warrior.
abstract: Given the results of the BARI and ARTS I trials and a meta-analysis, coronary artery bypass surgery has been preferred to percutaneous coronary intervention in diabetics with multivessel coronary artery disease requiring hypoglycemic treatment and in whom internal mammary artery grafts can be used. This approach was strongly recommended in a 2002 ACC/AHA Task Force on the management of patients with acute coronary syndrome. But, these recommendations were made before the availability of drug-eluting stents. We strongly believe that the ongoing, multi-centre FREEDOM, CARDia and SYNTAX trials will elucidate the optimal revascularization strategy for diabetic patients with multivessel disease in the near future.
authors: Turgay
authors: T
authors: Celik
authors: Atila
authors: A
authors: Iyisoy
authors: U Cagdas
authors: UC
authors: Yuksel
authors: Ersoy
authors: E
authors: Isik
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000379:methods / Q000639:trends; D002986:Clinical Trials as Topic / Q000379:methods / Q000639:trends; D001026:Coronary Artery Bypass / Q000379:methods / Q000639:trends; D003324:Coronary Artery Disease / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D048909:Diabetes Complications / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D054855:Drug-Eluting Stents / Q000639:trends; D006801:Humans; D009204:Myocardial Revascularization / Q000379:methods* / Q000639:trends*